Home > News > Nanotech imaging, molecular fingerprints and signatures hold promise
March 28th, 2004
Nanotech imaging, molecular fingerprints and signatures hold promise
Abstract:
Scientists described three novel advances aimed at early detection of cancer - a critical key to controlling or curing the disease. Through analysis of molecular fingerprints or genetic signatures, scientists have devised technology to identify ovarian or prostate cancer. A third technology produces magnetic resonance portraits that define the extent of early metastasis in breast cancer. Researchers described advances in imaging technology, proteomic and metabolomic analysis that may lead to improved quality of life for patients with breast, ovarian or prostate cancer. The new technologies were presented at the today 95th Annual Meeting of the American Association for Cancer Research here today.
Source:
EurekAlert
Bookmark:
Nanomedicine
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Announcements
JPK reports on single molecule research at IISER Pune in India using AFM and CellHesion techniques May 21st, 2013
Imec and GLOBALFOUNDRIES collaborate to advance high-density memory technology: STT-MRAM offers enhanced performance and scalability for embedded and standalone applications May 21st, 2013
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013